by newsworm | Mar 13, 2025 | Alkem, Glenmark, Mankind, Pharma
The price of the diabetes drug empagliflozin, also known as Jardiance, has been significantly reduced by almost one-tenth in India. The drug, developed by German pharma giant Boehringer Ingelheim, is used to control blood sugar levels in patients with type 2 diabetes.... by newsworm | Mar 12, 2025 | Alkem, Pharma
The Sulabh Alkem Award 2024 ceremony was held at the Integrated Multipurpose Hall in Pakyong, Sikkim, where Governor Om Prakash Mathur attended as the chief guest. The event recognized the outstanding contributions of individuals and institutions to sanitation and... by newsworm | Mar 11, 2025 | Alkem, Lupin, Mankind, Pharma, Torrent Pharma
The cost of Empagliflozin, a crucial drug for managing diabetes and its associated conditions, is set to drop significantly in India. The price of the medicine, which was previously around Rs 60 per tablet, will be reduced to just Rs 9 per tablet, making it more... by newsworm | Mar 9, 2025 | Alkem, Pharma
Here is a 400-word summary of the content: Alkem Laboratories, an Indian pharmaceutical company, has received the approval of a CDSCO (Central Drugs Standard Control Organization) panel to conduct a clinical trial of its Semaglutide tablet for the treatment of Type 2... by newsworm | Mar 1, 2025 | Alkem, Pharma
Alkem Laboratories Limited, a leading Indian pharmaceutical company, has appointed Sanjay Kumar Dipak as a member of their senior management team. This appointment aims to further strengthen the company’s management structure and pursue its growth ambitions.... by newsworm | Feb 26, 2025 | Alkem, Pharma
The Subject Expert Committee (SEC) of the Central Drug Standard Control Organisation (CDSCO) has approved Alkem Laboratories to conduct a Phase III clinical trial of semaglutide solution for injection, a glucagon-like peptide 1 receptor agonist used to improve...